{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:48:46Z","timestamp":1782334126854,"version":"3.54.5"},"reference-count":30,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2014,3,19]]},"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To examine how the population with fractured neck of femur has changed over the last decade and determine whether they have evolved to become a more physically and socially dependent cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective cohort study of prospectively collected Standardised Audit of Hip Fractures of Europe data entered on to an institutional hip fracture registry.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>10\u2005044 consecutive hip fracture admissions (2000\u20132012).<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>A major trauma centre in the UK.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There was a generalised increase in the number of admissions between 2000 (n=740) and 2012 (n=810). This increase was non-linear and best described by a quadratic curve. Assuming no change in the prevalence of hip fracture over the next 20\u2005years, our hospital is projected to treat 871 cases in 2020 and 925 in 2030. This represents an approximate year-on-year increase of just over 1%. There was an increase in the proportion of male admissions over the study period (2000: 174 of 740 admissions (23.5%); 2012: 249 of 810 admissions (30.7%)). This mirrored national census changes within the geographical area during the same period. During the study period there were significant increases in the numbers of patients admitted from their own home, the proportion of patients requiring assistance to mobilise, and the proportion of patients requiring help with basic activities of daily living (all p&lt;0.001). There was also a twofold to fourfold increase in the proportion of patients admitted with a diagnosis of cardiovascular disease, renal disease, diabetes and polypharmacy (use of &gt;4 prescribed medications; all p&lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The expanding hip fracture population has increasingly complex medical, social and rehabilitation care needs. This needs to be recognised so that appropriate healthcare strategies and service planning can be implemented. This epidemiological analysis allows projections of future service need in terms of patient numbers and dependency.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2013-004405","type":"journal-article","created":{"date-parts":[[2014,4,20]],"date-time":"2014-04-20T01:07:37Z","timestamp":1397956057000},"page":"e004405","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":100,"title":["Evolution of the hip fracture population: time to consider the future? A retrospective observational analysis"],"prefix":"10.1136","volume":"4","author":[{"given":"Paul N","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Salar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J","family":"Ollivere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daren P","family":"Forward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namal","family":"Weerasuriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain K","family":"Moppett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris G","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2014,4,19]]},"reference":[{"key":"2024051511401628000_4.4.e004405.1","unstructured":"Hip Fracture. Costing report. Implementing NICE guidance. National Institute for Health and Care Excellence clinical guideline 124. 2011."},{"key":"2024051511401628000_4.4.e004405.2","unstructured":"Osteoporosis Facts and Figures\u00a0v1.1 The National Osteoporosis Society publication. 2006."},{"key":"2024051511401628000_4.4.e004405.3","unstructured":"Johansen A Wakeman R Boulton C . National report 2013. Clinical Effectiveness and Evaluation Unit, Royal College of Physicians. National Hip Fracture Database."},{"key":"2024051511401628000_4.4.e004405.4","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.I.01763"},{"key":"2024051511401628000_4.4.e004405.5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.injury.2010.11.010","article-title":"Projected incidence of proximal femoral fractures in England: a report from the NHS Hip Fracture Anaesthesia Network (HIPFAN)","volume":"42","author":"White","year":"2011","journal-title":"Injury"},{"key":"2024051511401628000_4.4.e004405.6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.injury.2008.11.004","article-title":"Changes in population demographics and the future incidence of hip fracture","volume":"40","author":"Holt","year":"2009","journal-title":"Injury"},{"key":"2024051511401628000_4.4.e004405.7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.bone.2009.04.244","article-title":"Trends in hip fracture epidemiology in Australia: possible impact of bisphosphonates and hormone replacement therapy","volume":"45","author":"Fisher","year":"2009","journal-title":"Bone"},{"key":"2024051511401628000_4.4.e004405.8","unstructured":"British Orthopaedic Association and the British Geriatric Society. The Care of Patients with Fragility Fracture. Blue book publication by the British Orthopaedic Association, 2007."},{"key":"2024051511401628000_4.4.e004405.9","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00198-012-2020-z","article-title":"The health burden and costs of incident fractures attributable to osteoporosis from 2010 to 2050 in Germany\u2014a demographic simulation model","volume":"24","author":"Bleiber","year":"2013","journal-title":"Osteoporosis Int"},{"key":"2024051511401628000_4.4.e004405.10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00198-008-0781-1","article-title":"The health and economic consequences of osteopenia-and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050","volume":"20","author":"Konnopka","year":"2009","journal-title":"Osteoporosis Int"},{"key":"2024051511401628000_4.4.e004405.11","unstructured":"Currie C Partridge M Plant F . National report 2012. National Hip Fracture Database ."},{"key":"2024051511401628000_4.4.e004405.12","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcm051"},{"key":"2024051511401628000_4.4.e004405.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2008.03.022"},{"key":"2024051511401628000_4.4.e004405.14","unstructured":"Census Comparator: Office for National Statistics accessed at: http:\/\/www.ons.gov.uk\/ons\/interactive\/vp2-2011-census-comparator\/index.html. (accessed Sep 2013)."},{"key":"2024051511401628000_4.4.e004405.15","unstructured":"Census Results 2001: Nottinghamshire County Council. http:\/\/cms.nottinghamshire.gov.uk\/home\/business-economy\/econdata\/census2001\/censusresults.html (accessed Sep 2013)."},{"key":"2024051511401628000_4.4.e004405.16","unstructured":"Census 2011 Overview. Nottingham Insight. http:\/\/www.nottinghaminsight.org.uk\/insight\/key-datasets\/census-2011.aspx. (accessed Sep 2013)."},{"key":"2024051511401628000_4.4.e004405.17","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeq405"},{"key":"2024051511401628000_4.4.e004405.18","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aes187"},{"key":"2024051511401628000_4.4.e004405.19","unstructured":"About the Quality and Outcomes Framework. National Institute of Health and Care Excellence. http:\/\/www.nice.org.uk\/aboutnice\/qof (accessed Sep 2013)."},{"key":"2024051511401628000_4.4.e004405.20","unstructured":"Quality and Outcomes Framework. Online GP practice results database. QOF 2011\/12 results. http:\/\/www.qof.ic.nhs.uk. (accessed Sep 2013)."},{"key":"2024051511401628000_4.4.e004405.21","unstructured":"National Quality and Outcomes Framework Statistics 2004-05. August 2005. Health and Social Care Information Centre. http:\/\/www.hscic.gov.uk\/catalogue\/PUB01946 (accessed Sep 2013)."},{"key":"2024051511401628000_4.4.e004405.22","unstructured":"Quality and Outcomes Framework 2011-12. October 2012. Health and Social Care Information Centre. http:\/\/www.hscic.gov.uk\/catalogue\/PUB08135 (accessed Sep 2013)."},{"key":"2024051511401628000_4.4.e004405.23","unstructured":"Chronic Heart Failure. Management of chronic heart failure in adults in primary and secondary care. National Collaborating Centre for Chronic Conditions. National Institute for Health and Care Excellence Clinical Guideline 5. 2003."},{"key":"2024051511401628000_4.4.e004405.24","unstructured":"Diagnosis and Management of Type 1 diabetes in children, young people and adults. National collaborating centre for chronic conditions. National Institute for Health and Care Excellence Clinical Guideline 15. 2004."},{"key":"2024051511401628000_4.4.e004405.25","unstructured":"Hypertension (persistently high blood pressure) in adults. National Institute for Health and Care Excellence clinical guideline CG18. 2004."},{"key":"2024051511401628000_4.4.e004405.26","unstructured":"Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events. National Institute for Health and Care Excellence Technology Appraisal 90, 2005."},{"key":"2024051511401628000_4.4.e004405.27","unstructured":"Statins for the prevention of cardiovascular events in patients with increased risk of developing cardiovascular disease or those with established cardiovascular disease. National Institute for Health Care and Excellence Technology appraisal 94. 2006."},{"key":"2024051511401628000_4.4.e004405.28","unstructured":"The management of atrial fibrillation. National Institute for Health and Care Excellence clinical guidelines CG36."},{"key":"2024051511401628000_4.4.e004405.29","unstructured":"National Service Framework: coronary heart disease. Department of Health, 2000."},{"key":"2024051511401628000_4.4.e004405.30","unstructured":"Hip Fracture Anaesthesia Sprint Audit Project (ASAP). http:\/\/www.networks.nhs.uk\/nhs-networks\/hip-fracture-anaesthesia\/hip-fracture-anaesthesia-sprint-audit-project-asap ."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2013-004405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T18:43:38Z","timestamp":1715798618000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2013-004405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,19]]},"published-print":{"date-parts":[[2014,4]]}},"alternative-id":["10.1136\/bmjopen-2013-004405"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2013-004405","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}